Publicaciones en colaboración con investigadores/as de University Hospital of Lausanne (15)

2024

  1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

2023

  1. Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study

    Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003

2021

  1. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

2019

  1. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

    Mycoses, Vol. 62, Núm. 4, pp. 310-319

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

  2. Toxoplasmosis in transplant recipients, Europe, 2010–2014

    Emerging Infectious Diseases, Vol. 24, Núm. 8, pp. 1497-1504

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

  2. Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 4, pp. 1-3

2016

  1. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9, pp. 1-8

  2. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9

  3. Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

2011

  1. European expert opinion on the management of invasive candidiasis in adults

    Clinical Microbiology and Infection, Vol. 17, Núm. SUPPL. 5, pp. 1-12

2009

  1. Ventilator-associated pneumonia in patients undergoing major heart surgery: An incidence study in Europe

    Critical Care, Vol. 13, Núm. 3

2008

  1. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Clinical Infectious Diseases, Vol. 46, Núm. 12, pp. 1813-1821